The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
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
7kGYg2tEQzCnfZJ6
